Concepedia

Darin J. Gustin

DJ

Statistics

Publications

21

Citations

1K

H-Index

19

Active since

1994

Affiliations

Amgen (United States)(Current)

Indiana University Bloomington

Johnson & Johnson (United States)

University of Michigan

Scripps Research Institute

Darin J. Gustin is an author at Amgen (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

1994–2013

21

Publications

21

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text

, , +14

Structure guided design of a series of sphingosine kinase (SphK) inhibitors

Darin J. Gustin, Yihong Li, Matthew L. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 100 citations · Full text

, , +12

Design, Synthesis, and in Vitro Evaluation of Dipeptide-Based Antibody Minor Groove Binder Conjugates

Scott C. Jeffrey, Michael Torgov, Jamie B. Andreyka et al. · Journal of Medicinal Chemistry · 2005 · 90 citations

, , +17

Heavy Atom Isotope Effects Reveal a Highly Polarized Transition State for Chorismate Mutase

Darin J. Gustin, Patrizio Mattei, Peter Kast et al. · Journal of the American Chemical Society · 1999 · 88 citations

, , +16

Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability

Karen Rex, Shawn Jeffries, Matthew L. Brown et al. · PLoS ONE · 2013 · 65 citations · Full text

, , +15

1–5 of 21